Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



ORBIMED CAPITAL LLC Create: Alert

All | News | Filings
Date FiledTypeDescription
10/02/2023 144 Form 144 - Report of proposed sale of securities:
08/21/2023 144 Form 144 - Report of proposed sale of securities:
08/15/2023 144 Form 144 - Report of proposed sale of securities:
08/14/2023 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
07/31/2023 144 Form 144 - Report of proposed sale of securities:
07/25/2023 144 Form 144 - Report of proposed sale of securities:
07/13/2023 144 Form 144 - Report of proposed sale of securities:
06/12/2023 144 Form 144 - Report of proposed sale of securities:
05/24/2023 4 ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Prelude Therapeutics Inc
Txns: Bought 869,565 shares @ $5.75, valued at $5M
05/15/2023 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
05/08/2023 4 ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Bought 83,459 shares @ $2.75, valued at $229.5k
Bought 312,991 shares @ $2.75, valued at $860.7k
Bought 83,459 shares @ $2.75, valued at $229.5k
Bought 490,512 shares @ $2.82, valued at $1.4M
Bought 490,511 shares @ $2.82, valued at $1.4M
05/02/2023 4 ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Bought 60,998 shares @ $2.55, valued at $155.5k
Bought 228,754 shares @ $2.55, valued at $583.3k
Bought 60,997 shares @ $2.55, valued at $155.5k
Bought 124,544 shares @ $2.62, valued at $326.3k
Bought 467,068 shares @ $2.62, valued at $1.2M
Bought 124,545 shares @ $2.62, valued at $326.3k
Bought 58,826 shares @ $2.67, valued at $157.1k
Bought 220,610 shares @ $2.67, valued at $589k
Bought 58,826 shares @ $2.67, valued at $157.1k
04/05/2023 144 Form 144 - Report of proposed sale of securities:
02/23/2023 4 ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Granted 550,000 shares @ $0
Granted 550,000 shares @ $0
02/14/2023 SC 13G/A ORBIMED CAPITAL LLC reports a 0% stake in Milestone Pharmaceuticals, Inc.
11/14/2022 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
08/15/2022 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
07/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/16/2022 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
04/08/2022 4 ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns: Sold 162,000 shares @ $20.69, valued at $3.4M
Sold 171,204 shares @ $20.69, valued at $3.5M
Sold 167,800 shares @ $20.66, valued at $3.5M
Sold 177,196 shares @ $20.66, valued at $3.7M
Sold 97,200 shares @ $20.71, valued at $2M
Sold 102,800 shares @ $20.71, valued at $2.1M
03/31/2022 4 ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on PMV Pharmaceuticals, Inc.
Txns: Sold 365,000 shares @ $21.52, valued at $7.9M
Sold 75,000 shares @ $22.39, valued at $1.7M
Sold 34,500 shares @ $21.17, valued at $730.4k
02/15/2022 4 ORBIMED ADVISORS LLC (Director) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Bought 156,000 shares @ $10.22, valued at $1.6M
Bought 20,700 shares @ $9.98, valued at $206.6k
Bought 10,000 shares @ $9.89, valued at $98.9k
Bought 9,000 shares @ $9.96, valued at $89.6k
02/14/2022 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
02/11/2022 SC 13G ORBIMED CAPITAL LLC reports a 6.9% stake in SI-BONE, Inc.
02/11/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/11/2022 SC 13G ORBIMED CAPITAL LLC reports a 7% stake in Cybin Inc.
02/11/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/28/2022 4 ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Exercised (in-or-at-the-money) 374,962 options to buy @ $13.2, valued at $4.9M
Exercised (in-or-at-the-money) 56,244 options to buy @ $13.2, valued at $742.4k
Exercised (in-or-at-the-money) 56,244 options to buy @ $13.2, valued at $742.4k
11/15/2021 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
09/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/30/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/25/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy